Paxman publishes newsletter on media attention and marketing during Breast Cancer Awareness Month

27 October 2021 - 11:00

Today, Paxman publishes the October issue of its newsletter aimed at shareholders, investors and other interested parties.

This month’s issue highlights that Paxman was highlighted in several markets and also conducted a successful campaign in the United States during Breast Cancer Awareness Month in October. Entities and media highlighting Paxman Scalp cooling included Mayo Clinic Health System and the Good Morning America TV show in the USA, The Times of India, Brazilian TV and a national marketing campaign in Sweden in support of a breast cancer fund. Paxman’s #YouveGotThisCampaign was launched in the beginning of October and includes both digital and physical billboard advertising.

The newsletter also includes information on a survey by ASCO with 600 oncologists in the USA, which shows a significant positive attitude towards offering scalp cooling to most chemotherapy patients, international orders from Brazil, Hungary, France and Romania, and that Paxman has been successfully recertified by the Medical Device Single Audit Program.

To read the newsletter and subscribe for upcoming issues, follow this link:

Paxman’s investor newsletter is published monthly as a part of the company’s effort to strengthen its market communication together with the IR communication agency Honeybadger. Every published issue of the newsletter is available on Paxman’s website for investors, The company encourages feedback and requests on topics for upcoming issues of the newsletter.

Provided by: MFN
Nasdaq First North GM (Sweden)
Paxman AB
Paxman is a Sweden based company engages in the development of Paxman Scalp Cooling System that is used to minimize hair loss in connection with chemotherapy treatment. The company offers a stand-alone, mobile electric cooling unit, which is a liquid-based cooling system that cools down the patient's scalp through the silicone hat....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More